MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+0.51%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$11.2B
AUM Growth
-$244M
(-2.1%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$38.6M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$33.6M |
| 3 |
Moderna
MRNA
|
+$30.5M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$17.8M |
| 5 |
Match Group
MTCH
|
+$9.81M |
Top Sells
| 1 |
Energy Transfer Partners
ET
|
+$37.2M |
| 2 |
Microsoft
MSFT
|
+$13.8M |
| 3 |
Apple
AAPL
|
+$12.7M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$9.28M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$6.56M |
Sector Composition
| 1 | Technology | 21.21% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 12.66% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Communication Services | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
URG
2326
Ur-Energy
URG
$536M
| $130K | ﹤0.01% |
+75,333
| New | +$130K |
|
2327
Arbutus Biopharma
ABUS
$830M
| $129K | ﹤0.01% |
+30,042
| New | +$129K |
|
2328
Aligos Therapeutics
ALGS
$78M
| $129K | ﹤0.01% |
332
| – | – |
|
2329
Inseego
INSG
$193M
| $129K | ﹤0.01% |
1,934
-1,075
| -36% | -$71.6K |
|
2330
BeyondSpring
BYSI
$78.2M
| $129K | ﹤0.01% |
+8,173
| New | +$129K |
|
2331
El Pollo Loco
LOCO
$313M
| $128K | ﹤0.01% |
7,566
| – | – |
|
2332
Krispy Kreme
DNUT
$531M
| $128K | ﹤0.01% |
+9,122
| New | +$128K |
|
2333
SunCoke Energy
SXC
$639M
| $128K | ﹤0.01% |
20,308
-12,575
| -38% | -$79K |
|
|
PTVE
2334
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $127K | ﹤0.01% |
10,170
-7,610
| -43% | -$95.3K |
|
2335
Cato Corp
CATO
$87M
| $127K | ﹤0.01% |
7,694
| – | – |
|
2336
Rafael Holdings
RFL
$50.5M
| $127K | ﹤0.01% |
4,185
| – | – |
|
2337
RPC Inc
RES
$1.01B
| $127K | ﹤0.01% |
26,045
| – | – |
|
2338
Kiniksa Pharmaceuticals
KNSA
$2.73B
| $126K | ﹤0.01% |
11,087
| – | – |
|
2339
W&T Offshore
WTI
$257M
| $126K | ﹤0.01% |
33,784
+18,891
| +127% | +$70.3K |
|
2340
Couchbase
BASE
$1.35B
| $126K | ﹤0.01% |
+4,038
| New | +$126K |
|
2341
Cytosorbents Corp
CTSO
$62.6M
| $125K | ﹤0.01% |
+15,424
| New | +$125K |
|
|
BDSI
2342
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $125K | ﹤0.01% |
34,579
+26,128
| +309% | +$94.3K |
|
2343
Century Therapeutics
IPSC
$43.4M
| $124K | ﹤0.01% |
+4,939
| New | +$124K |
|
2344
Q32 Bio
QTTB
$21.7M
| $124K | ﹤0.01% |
+874
| New | +$124K |
|
2345
UroGen Pharma
URGN
$957M
| $124K | ﹤0.01% |
+7,354
| New | +$124K |
|
2346
Lexicon Pharmaceuticals
LXRX
$411M
| $123K | ﹤0.01% |
+25,604
| New | +$123K |
|
|
XONE
2347
DELISTED
The ExOne Company
XONE
| $123K | ﹤0.01% |
5,260
| – | – |
|
2348
European Wax Center
EWCZ
$166M
| $123K | ﹤0.01% |
+4,374
| New | +$123K |
|
2349
ANI Pharmaceuticals
ANIP
$2.14B
| $122K | ﹤0.01% |
+3,731
| New | +$122K |
|
2350
Spyre Therapeutics
SYRE
$1.01B
| $122K | ﹤0.01% |
+614
| New | +$122K |
|